Listed

Omega Healthcare Investors Inc

OHINYSECIK 888491Real estateFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$14.0m, Q2 FY2026
Operating income$330.9m, Q2 FY2026
Net income$362.8m, Q2 FY2026
Omega Healthcare Investors Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m242Revenue, Q3 FY2023, three months to 2023-09-30$242.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure239Revenue, Q4 FY2023, three months to 2023-12-31$239.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure243Revenue, Q1 FY2024, three months to 2024-03-31$243.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure253Revenue, Q2 FY2024, three months to 2024-06-30$252.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure276Revenue, Q3 FY2024, three months to 2024-09-30$276.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure279Revenue, Q4 FY2024, three months to 2024-12-31$279.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure277Revenue, Q1 FY2025, three months to 2025-03-31$276.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure283Revenue, Q2 FY2025, three months to 2025-06-30$282.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure312Revenue, Q3 FY2025, three months to 2025-09-30$311.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure319Revenue, Q4 FY2025, three months to 2025-12-31$319.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure6.7Revenue, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure14.0Revenue, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Operating income$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported281Operating income, Q2 FY2025, three months to 2025-06-30$281.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figurenot reportednot reportednot reported331Operating income, Q2 FY2026, three months to 2026-06-30$330.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m1.8Income tax, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure4.2Income tax, Q4 FY2023, three months to 2023-12-31$4.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure2.6Income tax, Q1 FY2024, three months to 2024-03-31$2.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure2.0Income tax, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure3.3Income tax, Q3 FY2024, three months to 2024-09-30$3.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure3.0Income tax, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure3.6Income tax, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure4.5Income tax, Q2 FY2025, three months to 2025-06-30$4.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure4.5Income tax, Q3 FY2025, three months to 2025-09-30$4.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure2.1Income tax, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure5.1Income tax, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure4.6Income tax, Q2 FY2026, three months to 2026-06-30$4.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Net income$m93.9Net income, Q3 FY2023, three months to 2023-09-30$93.9m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure49.9Net income, Q4 FY2023, three months to 2023-12-31$49.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure67.4Net income, Q1 FY2024, three months to 2024-03-31$67.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure114Net income, Q2 FY2024, three months to 2024-06-30$113.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure112Net income, Q3 FY2024, three months to 2024-09-30$111.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure113Net income, Q4 FY2024, three months to 2024-12-31$113.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure109Net income, Q1 FY2025, three months to 2025-03-31$109.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure137Net income, Q2 FY2025, three months to 2025-06-30$136.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure180Net income, Q3 FY2025, three months to 2025-09-30$179.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure165Net income, Q4 FY2025, three months to 2025-12-31$164.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure151Net income, Q1 FY2026, three months to 2026-03-31$151.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure363Net income, Q2 FY2026, three months to 2026-06-30$362.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Diluted EPS$ per share0.37Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figurenot reported0.27Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure0.45Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure0.42Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figurenot reported0.33Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure0.46Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure0.59Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figurenot reported0.47Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure1.19Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Basic EPS$ per share0.37Basic EPS, Q3 FY2023, three months to 2023-09-30$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figurenot reported0.27Basic EPS, Q1 FY2024, three months to 2024-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure0.46Basic EPS, Q2 FY2024, three months to 2024-06-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure0.43Basic EPS, Q3 FY2024, three months to 2024-09-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figurenot reported0.34Basic EPS, Q1 FY2025, three months to 2025-03-31$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure0.46Basic EPS, Q2 FY2025, three months to 2025-06-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure0.60Basic EPS, Q3 FY2025, three months to 2025-09-30$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figurenot reported0.47Basic EPS, Q1 FY2026, three months to 2026-03-31$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure1.21Basic EPS, Q2 FY2026, three months to 2026-06-30$1.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure

Balance sheet

Cash and equivalents$39.0m, Q2 FY2026
Long-term debt$4.26bn, FY2025
Shareholders' equity$5.39bn, Q2 FY2026
Omega Healthcare Investors Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn0.6Cash and equivalents, Q3 FY2023, at 2023-09-30$554.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure0.4Cash and equivalents, FY2023, at 2023-12-31$442.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure0.4Cash and equivalents, Q1 FY2024, at 2024-03-31$361.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure0.0Cash and equivalents, Q2 FY2024, at 2024-06-30$35.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure0.3Cash and equivalents, Q3 FY2024, at 2024-09-30$342.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure0.5Cash and equivalents, FY2024, at 2024-12-31$518.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure0.4Cash and equivalents, Q1 FY2025, at 2025-03-31$368.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure0.7Cash and equivalents, Q2 FY2025, at 2025-06-30$734.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure0.7Cash and equivalents, Q3 FY2025, at 2025-09-30$737.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure0.0Cash and equivalents, FY2025, at 2025-12-31$27.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure0.0Cash and equivalents, Q1 FY2026, at 2026-03-31$26.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure0.0Cash and equivalents, Q2 FY2026, at 2026-06-30$39.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Total assets$bn9.4Total assets, Q3 FY2023, at 2023-09-30$9.43bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0000888491-23-000033.Report this figure9.1Total assets, FY2023, at 2023-12-31$9.12bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure9.0Total assets, Q1 FY2024, at 2024-03-31$9.01bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-03, accession 0000888491-24-000030.Report this figure8.8Total assets, Q2 FY2024, at 2024-06-30$8.85bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-02, accession 0000888491-24-000036.Report this figure9.6Total assets, Q3 FY2024, at 2024-09-30$9.57bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure9.9Total assets, FY2024, at 2024-12-31$9.90bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure9.7Total assets, Q1 FY2025, at 2025-03-31$9.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure10.5Total assets, Q2 FY2025, at 2025-06-30$10.55bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure10.6Total assets, Q3 FY2025, at 2025-09-30$10.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure10.0Total assets, FY2025, at 2025-12-31$10.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure10.2Total assets, Q1 FY2026, at 2026-03-31$10.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure10.0Total assets, Q2 FY2026, at 2026-06-30$10.01bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Total liabilities$bn5.6Total liabilities, Q3 FY2023, at 2023-09-30$5.57bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0000888491-23-000033.Report this figure5.4Total liabilities, FY2023, at 2023-12-31$5.36bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure5.3Total liabilities, Q1 FY2024, at 2024-03-31$5.31bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-03, accession 0000888491-24-000030.Report this figure4.9Total liabilities, Q2 FY2024, at 2024-06-30$4.95bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-02, accession 0000888491-24-000036.Report this figure5.2Total liabilities, Q3 FY2024, at 2024-09-30$5.17bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure5.2Total liabilities, FY2024, at 2024-12-31$5.17bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure4.8Total liabilities, Q1 FY2025, at 2025-03-31$4.77bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure5.4Total liabilities, Q2 FY2025, at 2025-06-30$5.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure5.4Total liabilities, Q3 FY2025, at 2025-09-30$5.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure4.6Total liabilities, FY2025, at 2025-12-31$4.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure4.8Total liabilities, Q1 FY2026, at 2026-03-31$4.78bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure4.4Total liabilities, Q2 FY2026, at 2026-06-30$4.37bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Long-term debt$bn5.3Long-term debt, Q3 FY2023, at 2023-09-30$5.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-03, accession 0000888491-23-000033.Report this figure5.1Long-term debt, FY2023, at 2023-12-31$5.07bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure5.0Long-term debt, Q1 FY2024, at 2024-03-31$5.03bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-03, accession 0000888491-24-000030.Report this figure4.7Long-term debt, Q2 FY2024, at 2024-06-30$4.66bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-02, accession 0000888491-24-000036.Report this figure4.9Long-term debt, Q3 FY2024, at 2024-09-30$4.86bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure4.8Long-term debt, FY2024, at 2024-12-31$4.84bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure4.4Long-term debt, Q1 FY2025, at 2025-03-31$4.45bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure5.0Long-term debt, Q2 FY2025, at 2025-06-30$5.00bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure5.0Long-term debt, Q3 FY2025, at 2025-09-30$4.99bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure4.3Long-term debt, FY2025, at 2025-12-31$4.26bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figurenot reportednot reported
Shareholders' equity$bn3.7Shareholders' equity, Q3 FY2023, at 2023-09-30$3.67bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-03, accession 0000888491-23-000033.Report this figure3.6Shareholders' equity, FY2023, at 2023-12-31$3.57bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure3.5Shareholders' equity, Q1 FY2024, at 2024-03-31$3.51bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-03, accession 0000888491-24-000030.Report this figure3.7Shareholders' equity, Q2 FY2024, at 2024-06-30$3.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-02, accession 0000888491-24-000036.Report this figure4.2Shareholders' equity, Q3 FY2024, at 2024-09-30$4.21bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure4.5Shareholders' equity, FY2024, at 2024-12-31$4.54bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure4.7Shareholders' equity, Q1 FY2025, at 2025-03-31$4.74bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure5.0Shareholders' equity, Q2 FY2025, at 2025-06-30$4.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure5.0Shareholders' equity, Q3 FY2025, at 2025-09-30$5.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure5.2Shareholders' equity, FY2025, at 2025-12-31$5.18bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure5.2Shareholders' equity, Q1 FY2026, at 2026-03-31$5.19bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure5.4Shareholders' equity, Q2 FY2026, at 2026-06-30$5.39bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure

Cash flow

Operating cash flow$217.7m, Q2 FY2026
Omega Healthcare Investors Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m171Operating cash flow, Q3 FY2023, three months to 2023-09-30$171.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0000888491-24-000043. Derived: 9-month figure less the 6-month figure.Report this figure165Operating cash flow, Q4 FY2023, three months to 2023-12-31$165.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure151Operating cash flow, Q1 FY2024, three months to 2024-03-31$151.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure184Operating cash flow, Q2 FY2024, three months to 2024-06-30$184.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-01, accession 0000888491-25-000025. Derived: 6-month figure less the 3-month figure.Report this figure185Operating cash flow, Q3 FY2024, three months to 2024-09-30$184.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0000888491-25-000040. Derived: 9-month figure less the 6-month figure.Report this figure229Operating cash flow, Q4 FY2024, three months to 2024-12-31$229.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure182Operating cash flow, Q1 FY2025, three months to 2025-03-31$182.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure239Operating cash flow, Q2 FY2025, three months to 2025-06-30$239.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0000888491-26-000024. Derived: 6-month figure less the 3-month figure.Report this figure227Operating cash flow, Q3 FY2025, three months to 2025-09-30$226.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0000888491-25-000040. Derived: 9-month figure less the 6-month figure.Report this figure231Operating cash flow, Q4 FY2025, three months to 2025-12-31$230.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure216Operating cash flow, Q1 FY2026, three months to 2026-03-31$215.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure218Operating cash flow, Q2 FY2026, three months to 2026-06-30$217.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0000888491-26-000024. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m164Dividends paid, Q3 FY2023, three months to 2023-09-30$164.5m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-10-31, accession 0000888491-24-000043. Derived: 9-month figure less the 6-month figure.Report this figure165Dividends paid, Q4 FY2023, three months to 2023-12-31$164.6m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure165Dividends paid, Q1 FY2024, three months to 2024-03-31$164.8m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure166Dividends paid, Q2 FY2024, three months to 2024-06-30$166.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-01, accession 0000888491-25-000025. Derived: 6-month figure less the 3-month figure.Report this figure173Dividends paid, Q3 FY2024, three months to 2024-09-30$173.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-10-31, accession 0000888491-25-000040. Derived: 9-month figure less the 6-month figure.Report this figure181Dividends paid, Q4 FY2024, three months to 2024-12-31$181.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure189Dividends paid, Q1 FY2025, three months to 2025-03-31$189.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure195Dividends paid, Q2 FY2025, three months to 2025-06-30$194.6m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-07-30, accession 0000888491-26-000024. Derived: 6-month figure less the 3-month figure.Report this figure198Dividends paid, Q3 FY2025, three months to 2025-09-30$198.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-10-31, accession 0000888491-25-000040. Derived: 9-month figure less the 6-month figure.Report this figure198Dividends paid, Q4 FY2025, three months to 2025-12-31$198.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure198Dividends paid, Q1 FY2026, three months to 2026-03-31$198.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure200Dividends paid, Q2 FY2026, three months to 2026-06-30$200.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-07-30, accession 0000888491-26-000024. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)316.25m, Q2 FY2026
Omega Healthcare Investors Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares243Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30243,284,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0000888491-23-000033.Report this figure243Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31243,188,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-03, accession 0000888491-24-000030.Report this figure246Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30246,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-02, accession 0000888491-24-000036.Report this figure256Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30255,955,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0000888491-24-000043.Report this figure257Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31257,264,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-02, accession 0000888491-25-000016.Report this figure262Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30261,534,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-01, accession 0000888491-25-000025.Report this figure276Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30275,557,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure295Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31294,928,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure303Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30303,246,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure308Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30308,173,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure315Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31315,128,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure316Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30316,250,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure

Shares outstanding: 303.01mShares outstanding, period not labelled, at 2026-07-27303,013,000 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure at Jul 27, 2026, from the cover of the 10-Q filed Jul 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.